Search

Andrea Renee Schievella

from Port Jefferson, NY
Age ~58
Get Report
Also known as:
Andrea R Schievella, Andrea Karp
Related to:
Rachel M Anderson, 41
Connected to:
Brandon Schievelbein, 42Frank Schieve, 80James F Schieve, 106Johanna Schievelbein, 88John A Schieve, 86Julia A Schievelbein, 38Gregg C Schiewe, 70Susan L Schiewe, 75Zachary E Schiewer, 33Maria A Schiezzari, 71

Andrea Schievella Phones & Addresses

  • Port Jefferson, NY
  • Waltham, MA
  • 39 Edward Dr, Winchester, MA 01890 (781) 721-9724
  • Cambridge, MA

Resumes

Resumes

Andrea Schievella Photo 1

President

View page
Location:
39 Edward Dr, Winchester, MA 01890
Industry:
Biotechnology
Work:
Cancer Research Technology, Inc. since Apr 2008
Business Manager
MIT Technology Licensing Office May 2004 - Jan 2008
Technology Licensing Officer
Variagenics Jan 1997 - Feb 2003
Director, Business Development
Genetics Institute Jun 1993 - Dec 1996
Postdoctoral fellow
Education:
Harvard University 1988 - 1993
Ph.D., Cell and molecular biology Massachusetts Institute of Technology 1984 - 1988
B.S., Biology
Skills:
Biotechnology
Technology Transfer
Molecular Biology
Life Sciences
Cancer
Lifesciences
Licensing
Drug Discovery
Pharmaceutical Industry
Commercialization
Intellectual Property
Business Development
Oncology
Genomics
Patents
Drug Development
Cell
Cell Biology
Biochemistry
Languages:
English
Spanish
Andrea Schievella Photo 2

Andrea Schievella

View page

Publications

Us Patents

Tnf Receptor Death Domain Ligand Proteins And Inhibitors Of Ligand Binding

View page
US Patent:
7109307, Sep 19, 2006
Filed:
Nov 20, 2001
Appl. No.:
09/989350
Inventors:
Lih-Ling Lin - Concord MA, US
Jennifer Chen - Chestnut Hill MA, US
Andrea R. Schievella - Winchester MA, US
James Graham - Somerville MA, US
Assignee:
Genetics Institute, LLC - Cambridge MA
International Classification:
C07K 16/28
US Classification:
5303882, 4241391
Abstract:
Novel TNF receptor death domain (“TNF-R1-DD”) ligand proteins are disclosed. Polynucleotides encoding the TNF-R1-DD ligand protein are also disclosed, along with vectors, host cells, and methods of making the TNF-R1-DD ligand protein. Pharmaceutical compositions containing the TNF-R1-DD ligand protein, methods of treating inflammatory conditions, and methods of inhibiting TNF-R death domain binding are also disclosed. Methods of identifying inhibitors of TNF-R death domain binding and inhibitors identified by such methods are also disclosed.

Novel Tnf Receptor Death Domain Ligand Proteins And Inhibitors Of Ligand Binding

View page
US Patent:
20060188957, Aug 24, 2006
Filed:
Oct 7, 2005
Appl. No.:
11/245950
Inventors:
Lih-Ling Lin - Concord MA, US
Jennifer Chen - Chestnut Hill MA, US
Andrea Schievella - Winchester MA, US
James Graham - Somerville MA, US
International Classification:
C12P 21/06
C07H 21/04
C07K 14/715
C07K 16/30
US Classification:
435069100, 435320100, 435325000, 530350000, 530388220, 536023500
Abstract:
Novel TNF receptor death domain (“TNF-R1-DD”) ligand proteins are disclosed. Polynucleotides encoding the TNF-R1-DD ligand protein are also disclosed, along with vectors, host cells, and methods of making the TNF-R1-DD ligand protein. Pharmaceutical compositions containing the TNF-R1-DD ligand protein, methods of treating inflammatory conditions, and methods of inhibiting TNF-R death domain binding are also disclosed. Methods of identifying inhibitors of TNF-R death domain binding and inhibitors identified by such methods are also disclosed.

Novel Tnf Receptor Death Domain Ligand Proteins And Inhibitors Of Ligand Binding

View page
US Patent:
20090092613, Apr 9, 2009
Filed:
Feb 11, 2008
Appl. No.:
12/069735
Inventors:
Lih-Ling Lin - Concord MA, US
Jennifer Chen - Chestnut Hill MA, US
Andrea R. Schievella - Winchester MA, US
James Graham - Somerville MA, US
International Classification:
A61K 39/395
C12N 15/11
C12N 5/06
C12P 21/04
C07K 14/00
C12Q 1/68
A61K 38/16
C07K 16/18
G01N 33/566
US Classification:
4241391, 536 231, 435325, 435 691, 530350, 514 12, 5303879, 436501, 435 6
Abstract:
Novel TNF receptor death domain (“TNF-R1-DD”) ligand proteins are disclosed. Polynucleotides encoding the TNF-R1-DD ligand protein are also disclosed, along with vectors, host cells, and methods of making the TNF-R1-DD ligand protein. Pharmaceutical compositions containing the TNF-R1-DD ligand protein, methods of treating inflammatory conditions, and methods of inhibiting TNF-R death domain binding are also disclosed. Methods of identifying inhibitors of TNF-R death domain binding and inhibitors identified by such methods are also disclosed.

Tnf Receptor Death Domain Ligand Proteins And Method To Identify Inhibitors Of Ligand Binding

View page
US Patent:
58495010, Dec 15, 1998
Filed:
Jun 19, 1995
Appl. No.:
8/494440
Inventors:
Lih-Ling Lin - Concord MA
Jennifer Chen - Chestnut Hill MA
Andrea R. Schievella - Winchester MA
Assignee:
Genetics Institute, Inc. - Cambridge MA
International Classification:
G01N 33566
C07K 1471
C07K 14475
US Classification:
435 71
Abstract:
Novel TNF receptor death domain ("TNF-R1-DD") ligand proteins are disclosed. Polynucleotides encoding the TNF-R1-DD ligand protein are also disclosed, along with vectors, host cells, and methods of making the TNF-R1-DD ligand protein. Pharmaceutical compositions containing the TNF-R1-DD ligand protein, methods of treating inflammatory conditions, and methods of inhibiting TNF-R death domain binding are also disclosed. Methods of identifying inhibitors of TNF-R death domain binding and inhibitors identified by such methods are also disclosed.

Tnf Receptor Death Domain Ligand Proteins And Inhibitors Of Ligand Binding

View page
US Patent:
63229722, Nov 27, 2001
Filed:
Nov 2, 1998
Appl. No.:
9/185258
Inventors:
Lih-Ling Lin - Concord MA
Jennifer Chen - Chestnut Hill MA
Andrea R. Schievella - Winchester MA
James Graham - Somerville MA
Assignee:
Genetics Institute, Inc. - Cambridge MA
International Classification:
C12Q 168
G01N 3353
US Classification:
435 6
Abstract:
Novel TNF receptor death domain ("TNF-R1-DD") ligand proteins are disclosed. Polynucleotides encoding the TNF-R1-DD ligand protein are also disclosed, along with vectors, host cells, and methods of making the TNF-R1-DD ligand protein. Pharmaceutical compositions containing the TNF-R1-DD ligand protein, methods of treating inflammatory conditions, and methods of inhibiting TNF-R death domain binding are also disclosed. Methods of identifying inhibitors of TNF-R death domain binding and inhibitors identified by such methods are also disclosed.

Tnf Receptor Death Ligand Proteins And Inhibitors Of Ligand Binding

View page
US Patent:
58521739, Dec 22, 1998
Filed:
Sep 26, 1995
Appl. No.:
8/533901
Inventors:
Lih-Ling Lin - Concord MA
Jennifer Chen - Chestnut Hill MA
Andrea R. Schievella - Winchester MA
James Graham - Somerville MA
Assignee:
Genetics Institute, Inc. - Cambridge MA
International Classification:
C07K 1747
C07K 1452
C12N 1510
US Classification:
530350
Abstract:
Novel TNF receptor death domain ("TNF-R1-DD") ligand proteins are disclosed. Polynucleotides encoding the TNF-R1-DD ligand protein are also disclosed, along with vectors, host cells, and methods of making the TNF-R1-DD ligand protein. Pharmaceutical compositions containing the TNF-R1-DD ligand protein, methods of treating inflammatory conditions, and methods of inhibiting TNF-R death domain binding are also disclosed. Methods of identifying inhibitors of TNF-R death domain binding and inhibitors identified by such methods are also disclosed.

Tnf Receptor Death Domain Ligand Proteins

View page
US Patent:
59486384, Sep 7, 1999
Filed:
Apr 23, 1997
Appl. No.:
8/839031
Inventors:
Lih-Ling Lin - Concord MA
Jennifer Chen - Chestnut Hill MA
Andrea R. Schievella - Winchester MA
James Graham - Somerville MA
Assignee:
Genetics Institute, Inc. - Cambridge MA
International Classification:
C12N 1512
C12N 510
C12N 1510
C07K 1447
US Classification:
435 691
Abstract:
Novel TNF receptor death domain ("TNF-R1-DD") ligand proteins are disclosed. Polynucleotides encoding the TNF-R1-DD ligand protein are also disclosed, along with vectors, host cells, and methods of making the TNF-R1-DD ligand protein. Pharmaceutical compositions containing the TNF-R1-DD ligand protein, methods of treating inflammatory conditions, and methods of inhibiting TNF-R death domain binding are also disclosed. Methods of identifying inhibitors of TNF-R death domain binding and inhibitors identified by such methods are also disclosed.

Madd, A Tnf Receptor Death Domain Ligand Protein

View page
US Patent:
57123810, Jan 27, 1998
Filed:
Aug 15, 1996
Appl. No.:
8/698551
Inventors:
Lih-Ling Lin - Concord MA
Jennifer Chen - Chestnut Hill MA
Andrea R. Schievella - Winchester MA
James Graham - Somerville MA
Assignee:
Genetics Institute, Inc. - Cambridge MA
International Classification:
C07M 2104
C12N 1512
C12N 1585
C07K 14715
US Classification:
536 235
Abstract:
Novel TNF receptor death domain ("TNF-R1-DD") ligand proteins are disclosed. Polynucleotides encoding the TNF-R1-DD ligand protein are also disclosed, along with vectors, host cells, and methods of making the TNF-R1-DD ligand protein. Pharmaceutical compositions containing the TNF-R1-DD ligand protein, methods of treating inflammatory conditions, and methods of inhibiting TNF-R death domain binding are also disclosed. Methods of identifying inhibitors of TNF-R death domain binding and inhibitors identified by such methods are also disclosed.
Control profile
Andrea Renee Schievella from Port Jefferson, NY, age ~58 Get Report